(LDOS) Leidos Holdings - Ratings and Ratios
Software, Cybersecurity, Defense, Health, Aviation
LDOS EPS (Earnings per Share)
LDOS Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 28.4% |
| Value at Risk 5%th | 36.0% |
| Reward | |
|---|---|
| Sharpe Ratio | -0.09 |
| Alpha Jensen | -12.63 |
| Character | |
|---|---|
| Hurst Exponent | 0.516 |
| Beta | 0.589 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.86% |
| Mean DD | 11.96% |
Description: LDOS Leidos Holdings October 14, 2025
Leidos Holdings, Inc. (NYSE:LDOS) is a diversified technology and engineering firm that serves government and commercial customers in the U.S. and abroad, organized into four primary operating segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems.
The **National Security & Digital** segment delivers software, AI/ML-enabled services, cyber-operations, intelligence analysis, logistics, biometrics, CBRNE (chemical, biological, radiological, nuclear, explosives) solutions, training, and IT modernization for warfighters. In FY 2023 the segment generated roughly **$5.5 billion in revenue**, with a **backlog exceeding $10 billion**, reflecting strong demand for AI-driven defense tools. A key macro driver is the U.S. defense budget, which has risen **≈3 % YoY** and is increasingly earmarked for autonomous and cyber capabilities (source: DoD budget request FY 2025). *Assumption: FY 2024 revenue will track FY 2023 growth unless a major procurement cycle shift occurs.*
The **Health & Civil** segment provides air-traffic-control (ATC) systems, health-mission software, managed health services, infrastructure management, logistics support, and life-science R&D. FY 2023 revenue was about **$2.2 billion**, buoyed by a **12 % increase in ATC modernization contracts** and expanding Medicare Advantage enrollment, which drives demand for health-IT platforms. Sector-wide, the aging U.S. population and federal infrastructure spending (e.g., the 2021 Infrastructure Investment and Jobs Act) are expected to sustain growth in health-service outsourcing. *Uncertainty: potential policy shifts in healthcare reimbursement could alter the segment’s trajectory.*
The **Commercial & International** segment focuses on power-grid engineering, grid-modernization, utility consulting, energy-efficiency solutions, security-screening hardware (e.g., baggage scanners, explosive trace detectors), open-architecture airport-security platforms, biometric border-protection, IT service transformation, and aerial surveillance. Revenue for this segment was roughly **$2.0 billion** in FY 2023, with **grid-modernization contracts growing ~15 % YoY** as utilities upgrade aging infrastructure to meet renewable-energy targets. A broader driver is the global push toward smart-grid investments, projected to reach **$150 billion** in annual spend by 2027 (IEA). *Assumption: continued regulatory incentives for clean-energy upgrades will keep demand robust.*
The **Defense Systems** segment supplies airborne, air-and-missile defense, maritime, aerospace, and cyber-threat systems. It contributed about **$1.5 billion** to FY 2023 revenue, supported by new missile-defense contracts worth **$1.1 billion** announced in 2023. Geopolitical tensions in Eastern Europe and the Indo-Pacific region are accelerating procurement cycles for integrated air-and-missile defense solutions, a trend that underpins the segment’s outlook. *Uncertainty: any abrupt de-escalation in these regions could compress defense spending growth.*
For a deeper, data-driven dive into Leidos’ valuation metrics, competitive positioning, and scenario analysis, you may find the research tools on ValueRay useful for extending your analysis.
LDOS Stock Overview
| Market Cap in USD | 25,185m |
| Sub-Industry | IT Consulting & Other Services |
| IPO / Inception | 2006-10-13 |
| Return 12m vs S&P 500 | -16.4% |
| Analyst Rating | 4.06 of 5 |
LDOS Dividends
| Dividend Yield | 0.83% |
| Yield on Cost 5y | 1.70% |
| Yield CAGR 5y | 3.16% |
| Payout Consistency | 89.9% |
| Payout Ratio | 13.8% |
LDOS Growth Ratios
| CAGR | 23.89% |
| CAGR/Max DD Calmar Ratio | 0.65 |
| CAGR/Mean DD Pain Ratio | 2.00 |
| Current Volume | 876.2k |
| Average Volume | 749.2k |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (1.41b TTM) > 0 and > 6% of Revenue (6% = 1.04b TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 0.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 10.75% (prev 5.42%; Δ 5.32pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 1.55b > Net Income 1.41b (YES >=105%, WARN >=100%) |
| Net Debt (4.25b) to EBITDA (2.35b) ratio: 1.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.62 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (130.1m) change vs 12m ago -2.88% (target <= -2.0% for YES) |
| Gross Margin 17.61% (prev 16.59%; Δ 1.03pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 129.0% (prev 122.0%; Δ 6.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 10.18 (EBITDA TTM 2.35b / Interest Expense TTM 202.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.51
| (A) 0.14 = (Total Current Assets 4.85b - Total Current Liabilities 2.99b) / Total Assets 13.54b |
| (B) 0.32 = Retained Earnings (Balance) 4.38b / Total Assets 13.54b |
| (C) 0.15 = EBIT TTM 2.06b / Avg Total Assets 13.44b |
| (D) 0.50 = Book Value of Equity 4.32b / Total Liabilities 8.59b |
| Total Rating: 3.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 85.75
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 4.71% = 2.35 |
| 3. FCF Margin 8.00% = 2.00 |
| 4. Debt/Equity 1.07 = 1.96 |
| 5. Debt/Ebitda 1.81 = 0.37 |
| 6. ROIC - WACC (= 9.75)% = 12.19 |
| 7. RoE 30.81% = 2.50 |
| 8. Rev. Trend 96.82% = 7.26 |
| 9. EPS Trend 92.26% = 4.61 |
What is the price of LDOS shares?
Over the past week, the price has changed by -1.05%, over one month by +3.81%, over three months by +8.66% and over the past year by -3.09%.
Is Leidos Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LDOS is around 200.43 USD . This means that LDOS is currently overvalued and has a potential downside of 3.84%.
Is LDOS a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 7
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the LDOS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 215.6 | 11.7% |
| Analysts Target Price | 215.6 | 11.7% |
| ValueRay Target Price | 220.3 | 14.1% |
LDOS Fundamental Data Overview November 11, 2025
P/E Trailing = 18.375
P/E Forward = 15.674
P/S = 1.4531
P/B = 5.3083
P/EG = 2.34
Beta = 0.589
Revenue TTM = 17.33b USD
EBIT TTM = 2.06b USD
EBITDA TTM = 2.35b USD
Long Term Debt = 4.05b USD (from longTermDebt, last fiscal year)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 5.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.25b USD (from netDebt column, last quarter)
Enterprise Value = 29.44b USD (25.18b + Debt 5.23b - CCE 974.0m)
Interest Coverage Ratio = 10.18 (Ebit TTM 2.06b / Interest Expense TTM 202.0m)
FCF Yield = 4.71% (FCF TTM 1.39b / Enterprise Value 29.44b)
FCF Margin = 8.00% (FCF TTM 1.39b / Revenue TTM 17.33b)
Net Margin = 8.11% (Net Income TTM 1.41b / Revenue TTM 17.33b)
Gross Margin = 17.61% ((Revenue TTM 17.33b - Cost of Revenue TTM 14.28b) / Revenue TTM)
Gross Margin QoQ = 18.37% (prev 18.39%)
Tobins Q-Ratio = 2.17 (Enterprise Value 29.44b / Total Assets 13.54b)
Interest Expense / Debt = 0.98% (Interest Expense 51.0m / Debt 5.23b)
Taxrate = 23.76% (115.0m / 484.0m)
NOPAT = 1.57b (EBIT 2.06b * (1 - 23.76%))
Current Ratio = 1.62 (Total Current Assets 4.85b / Total Current Liabilities 2.99b)
Debt / Equity = 1.07 (Debt 5.23b / totalStockholderEquity, last quarter 4.91b)
Debt / EBITDA = 1.81 (Net Debt 4.25b / EBITDA 2.35b)
Debt / FCF = 3.07 (Net Debt 4.25b / FCF TTM 1.39b)
Total Stockholder Equity = 4.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.38% (Net Income 1.41b / Total Assets 13.54b)
RoE = 30.81% (Net Income TTM 1.41b / Total Stockholder Equity 4.56b)
RoCE = 23.89% (EBIT 2.06b / Capital Employed (Equity 4.56b + L.T.Debt 4.05b))
RoIC = 16.66% (NOPAT 1.57b / Invested Capital 9.41b)
WACC = 6.91% (E(25.18b)/V(30.41b) * Re(8.19%) + D(5.23b)/V(30.41b) * Rd(0.98%) * (1-Tc(0.24)))
Discount Rate = 8.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.89%
[DCF Debug] Terminal Value 78.81% ; FCFE base≈1.36b ; Y1≈1.46b ; Y5≈1.79b
Fair Price DCF = 238.1 (DCF Value 30.44b / Shares Outstanding 127.9m; 5y FCF grow 8.43% → 3.0% )
EPS Correlation: 92.26 | EPS CAGR: 20.41% | SUE: 1.38 | # QB: 3
Revenue Correlation: 96.82 | Revenue CAGR: 7.14% | SUE: 2.92 | # QB: 1
Additional Sources for LDOS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle